Annexon is a speculative Buy due to its late-stage Tanruprubart program targeting the high unmet need in Guillain-Barré Syndrome. Tanruprubart could become the standard of care for GBS if approved, given the lack of FDA-approved therapies and limited competition. The company faces near-term risks: delayed regulatory filings, high cash burn, and a likely need for additional funding within a year.

GS gears up for Q2 earnings as market-making, IPOs and lending shine, but will rising expenses weigh on results? Let us find out.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Business Financial Services (FBIZ) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Univest (UVSP) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Popular (BPOP) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Bancorp (FBP) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Northrim (NRIM) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Essential Utilities (WTRG) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Invesco (IVZ) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does TIM (TIMB) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Atmos (ATO) have what it takes?

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

Red Cat Holdings, Inc. is well positioned to benefit from increased U.S. and EU defense spending. They now have multiple drones on the Blue UAS approved list. The company has a robust drone lineup, especially the Teal 2 and Black Widow, which gives it a competitive edge in SSR contract procurement. Despite current unprofitability, strong sales potential, particularly from the Black Widow, could drive Red Cat to profitability by year-end, with a target of $120 million in revenue.

ALAB's strong portfolio makes its top-line growth prospects bright. However, stiff competition and stretched valuation make the stock a risky bet.

OPFI's tech-driven lending model, strong liquidity, and loyal customer base support its long-term hold potential.

Investors with an interest in Retail - Apparel and Shoes stocks have likely encountered both Urban Outfitters (URBN) and Boot Barn (BOOT). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in stocks from the Mining - Gold sector have probably already heard of Kinross Gold (KGC) and Agnico Eagle Mines (AEM). But which of these two stocks is more attractive to value investors?

Investors looking for stocks in the Computers - IT Services sector might want to consider either Cognizant (CTSH) or Epam (EPAM). But which of these two stocks offers value investors a better bang for their buck right now?

Investors looking for stocks in the REIT and Equity Trust - Residential sector might want to consider either NexPoint Residential Trust Inc. (NXRT) or Essex Property Trust (ESS). But which of these two stocks presents investors with the better value opportunity right now?

Investors interested in stocks from the Banks - Foreign sector have probably already heard of Banco Macro (BMA) and Banco Itau (ITUB). But which of these two stocks offers value investors a better bang for their buck right now?